[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Lipid Nanoparticles (LNP) Industry Research Report 2023

August 2023 | 86 pages | ID: L8A185E35740EN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Highlights

The global Lipid Nanoparticles (LNP) market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.

North American market for Lipid Nanoparticles (LNP) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

Asia-Pacific market for Lipid Nanoparticles (LNP) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

The major global companies of Lipid Nanoparticles (LNP) include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical and Lipoid, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

The global market for Lipid Nanoparticles (LNP) in Vaccines and Drugs is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, mRNA-lipid Nanoparticle, which accounted for % of the global market of Lipid Nanoparticles (LNP) in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lipid Nanoparticles (LNP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid Nanoparticles (LNP).

The Lipid Nanoparticles (LNP) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lipid Nanoparticles (LNP) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lipid Nanoparticles (LNP) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Precision NanoSystems
  • Evonik
  • Merck KGaA
  • Genevant Sciences
  • Exelead
  • Avanti Polar Lipids
  • Nippon Fine Chemical
  • Lipoid
Product Type Insights

Global markets are presented by Lipid Nanoparticles (LNP) type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Lipid Nanoparticles (LNP) are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).

Lipid Nanoparticles (LNP) segment by Type
  • mRNA-lipid Nanoparticle
  • siRNA-lipid Nanoparticle
  • Others
Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).

This report also outlines the market trends of each segment and consumer behaviors impacting the Lipid Nanoparticles (LNP) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Lipid Nanoparticles (LNP) market.

Lipid Nanoparticles (LNP) Segment by Application
  • Vaccines and Drugs
  • Scientific Research
Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Lipid Nanoparticles (LNP) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticles (LNP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticles (LNP) and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Lipid Nanoparticles (LNP) industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticles (LNP).

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Lipid Nanoparticles (LNP) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Lipid Nanoparticles (LNP) by Type
  2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
  1.2.2 mRNA-lipid Nanoparticle
  1.2.3 siRNA-lipid Nanoparticle
  1.2.4 Others
2.3 Lipid Nanoparticles (LNP) by Application
  2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
  2.3.2 Vaccines and Drugs
  2.3.3 Scientific Research
2.4 Assumptions and Limitations

3 LIPID NANOPARTICLES (LNP) BREAKDOWN DATA BY TYPE

3.1 Global Lipid Nanoparticles (LNP) Historic Market Size by Type (2018-2023)
3.2 Global Lipid Nanoparticles (LNP) Forecasted Market Size by Type (2023-2028)

4 LIPID NANOPARTICLES (LNP) BREAKDOWN DATA BY APPLICATION

4.1 Global Lipid Nanoparticles (LNP) Historic Market Size by Application (2018-2023)
4.2 Global Lipid Nanoparticles (LNP) Forecasted Market Size by Application (2018-2023)

5 GLOBAL GROWTH TRENDS

5.1 Global Lipid Nanoparticles (LNP) Market Perspective (2018-2029)
5.2 Global Lipid Nanoparticles (LNP) Growth Trends by Region
  5.2.1 Global Lipid Nanoparticles (LNP) Market Size by Region: 2018 VS 2022 VS 2029
  5.2.2 Lipid Nanoparticles (LNP) Historic Market Size by Region (2018-2023)
  5.2.3 Lipid Nanoparticles (LNP) Forecasted Market Size by Region (2024-2029)
5.3 Lipid Nanoparticles (LNP) Market Dynamics
  5.3.1 Lipid Nanoparticles (LNP) Industry Trends
  5.3.2 Lipid Nanoparticles (LNP) Market Drivers
  5.3.3 Lipid Nanoparticles (LNP) Market Challenges
  5.3.4 Lipid Nanoparticles (LNP) Market Restraints

6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS

6.1 Global Top Lipid Nanoparticles (LNP) Players by Revenue
  6.1.1 Global Top Lipid Nanoparticles (LNP) Players by Revenue (2018-2023)
  6.1.2 Global Lipid Nanoparticles (LNP) Revenue Market Share by Players (2018-2023)
6.2 Global Lipid Nanoparticles (LNP) Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Lipid Nanoparticles (LNP) Head office and Area Served
6.4 Global Lipid Nanoparticles (LNP) Players, Product Type & Application
6.5 Global Lipid Nanoparticles (LNP) Players, Date of Enter into This Industry
6.6 Global Lipid Nanoparticles (LNP) Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 NORTH AMERICA

7.1 North America Lipid Nanoparticles (LNP) Market Size (2018-2029)
7.2 North America Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Lipid Nanoparticles (LNP) Market Size by Country (2018-2023)
7.4 North America Lipid Nanoparticles (LNP) Market Size by Country (2024-2029)
7.5 United States
7.6 Canada

8 EUROPE

8.1 Europe Lipid Nanoparticles (LNP) Market Size (2018-2029)
8.2 Europe Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Lipid Nanoparticles (LNP) Market Size by Country (2018-2023)
8.4 Europe Lipid Nanoparticles (LNP) Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries

9 ASIA-PACIFIC

9.1 Asia-Pacific Lipid Nanoparticles (LNP) Market Size (2018-2029)
9.2 Asia-Pacific Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Lipid Nanoparticles (LNP) Market Size by Country (2018-2023)
9.4 Asia-Pacific Lipid Nanoparticles (LNP) Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia

10 LATIN AMERICA

10.1 Latin America Lipid Nanoparticles (LNP) Market Size (2018-2029)
10.2 Latin America Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Lipid Nanoparticles (LNP) Market Size by Country (2018-2023)
10.4 Latin America Lipid Nanoparticles (LNP) Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Lipid Nanoparticles (LNP) Market Size (2018-2029)
11.2 Middle East & Africa Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Country (2018-2023)
11.4 Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE

12 PLAYERS PROFILED

11.1 Precision NanoSystems
  11.1.1 Precision NanoSystems Company Detail
  11.1.2 Precision NanoSystems Business Overview
  11.1.3 Precision NanoSystems Lipid Nanoparticles (LNP) Introduction
  11.1.4 Precision NanoSystems Revenue in Lipid Nanoparticles (LNP) Business (2017-2022)
  11.1.5 Precision NanoSystems Recent Development
11.2 Evonik
  11.2.1 Evonik Company Detail
  11.2.2 Evonik Business Overview
  11.2.3 Evonik Lipid Nanoparticles (LNP) Introduction
  11.2.4 Evonik Revenue in Lipid Nanoparticles (LNP) Business (2017-2022)
  11.2.5 Evonik Recent Development
11.3 Merck KGaA
  11.3.1 Merck KGaA Company Detail
  11.3.2 Merck KGaA Business Overview
  11.3.3 Merck KGaA Lipid Nanoparticles (LNP) Introduction
  11.3.4 Merck KGaA Revenue in Lipid Nanoparticles (LNP) Business (2017-2022)
  11.3.5 Merck KGaA Recent Development
11.4 Genevant Sciences
  11.4.1 Genevant Sciences Company Detail
  11.4.2 Genevant Sciences Business Overview
  11.4.3 Genevant Sciences Lipid Nanoparticles (LNP) Introduction
  11.4.4 Genevant Sciences Revenue in Lipid Nanoparticles (LNP) Business (2017-2022)
  11.4.5 Genevant Sciences Recent Development
11.5 Exelead
  11.5.1 Exelead Company Detail
  11.5.2 Exelead Business Overview
  11.5.3 Exelead Lipid Nanoparticles (LNP) Introduction
  11.5.4 Exelead Revenue in Lipid Nanoparticles (LNP) Business (2017-2022)
  11.5.5 Exelead Recent Development
11.6 Avanti Polar Lipids
  11.6.1 Avanti Polar Lipids Company Detail
  11.6.2 Avanti Polar Lipids Business Overview
  11.6.3 Avanti Polar Lipids Lipid Nanoparticles (LNP) Introduction
  11.6.4 Avanti Polar Lipids Revenue in Lipid Nanoparticles (LNP) Business (2017-2022)
  11.6.5 Avanti Polar Lipids Recent Development
11.7 Nippon Fine Chemical
  11.7.1 Nippon Fine Chemical Company Detail
  11.7.2 Nippon Fine Chemical Business Overview
  11.7.3 Nippon Fine Chemical Lipid Nanoparticles (LNP) Introduction
  11.7.4 Nippon Fine Chemical Revenue in Lipid Nanoparticles (LNP) Business (2017-2022)
  11.7.5 Nippon Fine Chemical Recent Development
11.8 Lipoid
  11.8.1 Lipoid Company Detail
  11.8.2 Lipoid Business Overview
  11.8.3 Lipoid Lipid Nanoparticles (LNP) Introduction
  11.8.4 Lipoid Revenue in Lipid Nanoparticles (LNP) Business (2017-2022)
  11.8.5 Lipoid Recent Development

13 REPORT CONCLUSION


14 DISCLAIMER


LIST OF TABLES

Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Lipid Nanoparticles (LNP) Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Lipid Nanoparticles (LNP) Revenue Market Share by Type (2018-2023)
Table 7. Global Lipid Nanoparticles (LNP) Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Lipid Nanoparticles (LNP) Revenue Market Share by Type (2024-2029)
Table 9. Global Lipid Nanoparticles (LNP) Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2018-2023)
Table 11. Global Lipid Nanoparticles (LNP) Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2024-2029)
Table 13. Global Lipid Nanoparticles (LNP) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Lipid Nanoparticles (LNP) Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Lipid Nanoparticles (LNP) Market Share by Region (2018-2023)
Table 16. Global Lipid Nanoparticles (LNP) Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Lipid Nanoparticles (LNP) Market Share by Region (2024-2029)
Table 18. Lipid Nanoparticles (LNP) Market Trends
Table 19. Lipid Nanoparticles (LNP) Market Drivers
Table 20. Lipid Nanoparticles (LNP) Market Challenges
Table 21. Lipid Nanoparticles (LNP) Market Restraints
Table 22. Global Top Lipid Nanoparticles (LNP) Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Lipid Nanoparticles (LNP) Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Lipid Nanoparticles (LNP) Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Lipid Nanoparticles (LNP), Headquarters and Area Served
Table 26. Global Lipid Nanoparticles (LNP) Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Lipid Nanoparticles (LNP) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Lipid Nanoparticles (LNP) Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Lipid Nanoparticles (LNP) Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Lipid Nanoparticles (LNP) Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Lipid Nanoparticles (LNP) Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Lipid Nanoparticles (LNP) Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Lipid Nanoparticles (LNP) Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Lipid Nanoparticles (LNP) Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Lipid Nanoparticles (LNP) Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Country (2024-2029) & (US$ Million)
Table 45. Precision NanoSystems Company Detail
Table 46. Precision NanoSystems Business Overview
Table 47. Precision NanoSystems Lipid Nanoparticles (LNP) Product
Table 48. Precision NanoSystems Revenue in Lipid Nanoparticles (LNP) Business (2017-2022) & (US$ Million)
Table 49. Precision NanoSystems Recent Development
Table 50. Evonik Company Detail
Table 51. Evonik Business Overview
Table 52. Evonik Lipid Nanoparticles (LNP) Product
Table 53. Evonik Revenue in Lipid Nanoparticles (LNP) Business (2017-2022) & (US$ Million)
Table 54. Evonik Recent Development
Table 55. Merck KGaA Company Detail
Table 56. Merck KGaA Business Overview
Table 57. Merck KGaA Lipid Nanoparticles (LNP) Product
Table 58. Merck KGaA Revenue in Lipid Nanoparticles (LNP) Business (2017-2022) & (US$ Million)
Table 59. Merck KGaA Recent Development
Table 60. Genevant Sciences Company Detail
Table 61. Genevant Sciences Business Overview
Table 62. Genevant Sciences Lipid Nanoparticles (LNP) Product
Table 63. Genevant Sciences Revenue in Lipid Nanoparticles (LNP) Business (2017-2022) & (US$ Million)
Table 64. Genevant Sciences Recent Development
Table 65. Exelead Company Detail
Table 66. Exelead Business Overview
Table 67. Exelead Lipid Nanoparticles (LNP) Product
Table 68. Exelead Revenue in Lipid Nanoparticles (LNP) Business (2017-2022) & (US$ Million)
Table 69. Exelead Recent Development
Table 70. Avanti Polar Lipids Company Detail
Table 71. Avanti Polar Lipids Business Overview
Table 72. Avanti Polar Lipids Lipid Nanoparticles (LNP) Product
Table 73. Avanti Polar Lipids Revenue in Lipid Nanoparticles (LNP) Business (2017-2022) & (US$ Million)
Table 74. Avanti Polar Lipids Recent Development
Table 75. Nippon Fine Chemical Company Detail
Table 76. Nippon Fine Chemical Business Overview
Table 77. Nippon Fine Chemical Lipid Nanoparticles (LNP) Product
Table 78. Nippon Fine Chemical Revenue in Lipid Nanoparticles (LNP) Business (2017-2022) & (US$ Million)
Table 79. Nippon Fine Chemical Recent Development
Table 80. Lipoid Company Detail
Table 81. Lipoid Business Overview
Table 82. Lipoid Lipid Nanoparticles (LNP) Product
Table 83. Lipoid Revenue in Lipid Nanoparticles (LNP) Business (2017-2022) & (US$ Million)
Table 84. Lipoid Recent Development
Table 85. Precision NanoSystems Company Information
Table 86. Precision NanoSystems Business Overview
Table 87. Precision NanoSystems Lipid Nanoparticles (LNP) Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million)
Table 88. Precision NanoSystems Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million) Portfolio
Table 89. Precision NanoSystems Recent Development
Table 90. Evonik Company Information
Table 91. Evonik Business Overview
Table 92. Evonik Lipid Nanoparticles (LNP) Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million)
Table 93. Evonik Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million) Portfolio
Table 94. Evonik Recent Development
Table 95. Merck KGaA Company Information
Table 96. Merck KGaA Business Overview
Table 97. Merck KGaA Lipid Nanoparticles (LNP) Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million)
Table 98. Merck KGaA Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million) Portfolio
Table 99. Merck KGaA Recent Development
Table 100. Genevant Sciences Company Information
Table 101. Genevant Sciences Business Overview
Table 102. Genevant Sciences Lipid Nanoparticles (LNP) Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million)
Table 103. Genevant Sciences Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million) Portfolio
Table 104. Genevant Sciences Recent Development
Table 105. Exelead Company Information
Table 106. Exelead Business Overview
Table 107. Exelead Lipid Nanoparticles (LNP) Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million)
Table 108. Exelead Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million) Portfolio
Table 109. Exelead Recent Development
Table 110. Avanti Polar Lipids Company Information
Table 111. Avanti Polar Lipids Business Overview
Table 112. Avanti Polar Lipids Lipid Nanoparticles (LNP) Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million)
Table 113. Avanti Polar Lipids Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million) Portfolio
Table 114. Avanti Polar Lipids Recent Development
Table 115. Nippon Fine Chemical Company Information
Table 116. Nippon Fine Chemical Business Overview
Table 117. Nippon Fine Chemical Lipid Nanoparticles (LNP) Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million)
Table 118. Nippon Fine Chemical Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million) Portfolio
Table 119. Nippon Fine Chemical Recent Development
Table 120. Lipoid Company Information
Table 121. Lipoid Business Overview
Table 122. Lipoid Lipid Nanoparticles (LNP) Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million)
Table 123. Lipoid Revenue in Lipid Nanoparticles (LNP) Business (2018-2023) & (US$ Million) Portfolio


More Publications